Compare $ABVC vs $BIOQ | Chartloom

Compare

$ABVC vs $BIOQ

ABVC Biopharma Inc · Bioqual Inc

ABVC

ABVC Biopharma Inc

BIOQ

Bioqual Inc

Compare $ABVC vs $BIOQ

Comparing ABVC Biopharma Inc and Bioqual Inc

ABVCABVC Biopharma Inc

BIOQBioqual Inc

ABVCABVC Biopharma Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-54.3%

52W performance

-69.1%

FCF yield

-10.4%

BIOQBioqual Inc

Market cap

$29M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.4%

YTD performance

-14.3%

52W performance

-40.0%

FCF yield

20.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABVC

BIOQ

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

BIOQ

Bioqual Inc

Market Cap

ABVC$26M

BIOQ$29M

Enterprise Value

ABVC$27M

BIOQ$18M

Price

ABVC$1.00

BIOQ$33.00

P/E Ratio

ABVCN/A

BIOQN/A

P/S Ratio

ABVC39.44x

BIOQ0.69x

EV/Sales

ABVC40.47x

BIOQ0.43x

EV/EBITDA

ABVC0.00x

BIOQ7.55x

P/B Ratio

ABVC3.06x

BIOQ0.84x

P/FCF Ratio

ABVCN/A

BIOQ4.95x

EV/FCF

ABVC-9.95x

BIOQ3.05x

PEG Ratio

ABVCN/A

BIOQN/A

Forward P/E (NTM)

ABVCN/A

BIOQN/A

Forward P/S (NTM)

ABVCN/A

BIOQN/A

Revenue (TTM)

ABVC$0

BIOQ$42M

Revenue Growth (YoY)

ABVC-100.0%

BIOQ-19.4%

Forward Rev Growth

ABVC0.0%

BIOQ0.0%

Gross Margin (TTM)

ABVC0.3%

BIOQ7.9%

Operating Margin (TTM)

ABVC0.0%

BIOQ0.0%

EBITDA Margin (TTM)

ABVC0.0%

BIOQ-0.1%

Net Margin (TTM)

ABVC0.0%

BIOQ-2.9%

FCF Margin (TTM)

ABVCN/A

BIOQ14.0%

Net Income (TTM)

ABVC$-8M

BIOQ$-1M

FCF (TTM)

ABVC$-3M

BIOQ$6M

EPS (TTM)

ABVC-$0.30

BIOQ-$1.38

ROE (TTM)

ABVC-7147.0%

BIOQ-346.0%

ROA (TTM)

ABVC-3883.0%

BIOQ-193.0%

ROIC (TTM)

ABVC-6509.0%

BIOQ-346.0%

Cash

ABVC$32K

BIOQ$11M

Debt

ABVC$859K

BIOQ$0

Net Cash/Debt

ABVC$-827K

BIOQ$11M

Current Ratio (TTM)

ABVC0.07x

BIOQ4.01x

Quick Ratio (TTM)

ABVC0.05x

BIOQ3.91x

Debt/Equity (TTM)

ABVC0.08x

BIOQ0.00x

Debt/Assets (TTM)

ABVC0.0%

BIOQ0.0%

Interest Coverage (TTM)

ABVCN/A

BIOQN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

BIOQ0.00x

Beta

ABVC0.50

BIOQ-0.48

52W Performance

ABVC-69.1%

BIOQ-40.0%

YTD Performance

ABVC-54.3%

BIOQ-14.3%

% from 52W High

ABVC-70.0%

BIOQ-69.6%

% from 52W Low

ABVC40.8%

BIOQ1.5%

Asset Turnover (TTM)

ABVC0.06x

BIOQ0.66x

FCF Yield (TTM)

ABVC-10.4%

BIOQ20.2%

Earnings Yield (TTM)

ABVC-30.4%

BIOQ-4.2%

Dividend Yield (TTM)

ABVCN/A

BIOQN/A

Rule of 40

ABVC-100.0

BIOQ-5.4

EV/GP/RG

ABVCN/A

BIOQN/A

Ticker research

View ABVC research View BIOQ research

Metric	ABVC ABVC Biopharma Inc	BIOQ Bioqual Inc
Market & Valuation
Market Cap	$26M	$29M
Enterprise Value	$27M	$18M
Price	$1.00	$33.00
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	0.69x
EV/Sales	40.47x	0.43x
EV/EBITDA	0.00x	7.55x
P/B Ratio	3.06x	0.84x
P/FCF Ratio	N/A	4.95x
EV/FCF	-9.95x	3.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$42M
Revenue Growth (YoY)	-100.0%	-19.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.3%	7.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-0.1%
Net Margin (TTM)	0.0%	-2.9%
FCF Margin (TTM)	N/A	14.0%
Net Income (TTM)	$-8M	$-1M
FCF (TTM)	$-3M	$6M
EPS (TTM)	-$0.30	-$1.38
ROE (TTM)	-7147.0%	-346.0%
ROA (TTM)	-3883.0%	-193.0%
ROIC (TTM)	-6509.0%	-346.0%
Financial Health
Cash	$32K	$11M
Debt	$859K	$0
Net Cash/Debt	$-827K	$11M
Current Ratio (TTM)	0.07x	4.01x
Quick Ratio (TTM)	0.05x	3.91x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	-0.48
52W Performance	-69.1%	-40.0%
YTD Performance	-54.3%	-14.3%
% from 52W High	-70.0%	-69.6%
% from 52W Low	40.8%	1.5%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.66x
FCF Yield (TTM)	-10.4%	20.2%
Earnings Yield (TTM)	-30.4%	-4.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-5.4
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View BIOQ research

Valuation

P/S Ratio

BIOQ

0.69x

ABVC

39.44x

EV/FCF

ABVC

-9.95x

BIOQ

3.05x

Growth & revenue

Revenue Growth TTM

BIOQ

-19.4%

ABVC

-100.0%

Forward Revenue Growth

ABVC

0.0%

BIOQ

0.0%

Profitability & performance

Gross Margin

BIOQ

7.9%

ABVC

0.3%

ROE

BIOQ

-346.0%

ABVC

-7147.0%

FCF Yield %

BIOQ

20.2%

ABVC

-10.4%

52-Week Performance

BIOQ

-40.0%

ABVC

-69.1%

Detailed metrics comparison

ABVC

ABVC Biopharma Inc

BIOQ

Bioqual Inc

Market Cap

ABVC$26M

BIOQ$29M

Enterprise Value

ABVC$27M

BIOQ$18M

Price

ABVC$1.00

BIOQ$33.00

P/E Ratio

ABVCN/A

BIOQN/A

P/S Ratio

ABVC39.44x

BIOQ0.69x

EV/Sales

ABVC40.47x

BIOQ0.43x

EV/EBITDA

ABVC0.00x

BIOQ7.55x

P/B Ratio

ABVC3.06x

BIOQ0.84x

P/FCF Ratio

ABVCN/A

BIOQ4.95x

EV/FCF

ABVC-9.95x

BIOQ3.05x

PEG Ratio

ABVCN/A

BIOQN/A

Forward P/E (NTM)

ABVCN/A

BIOQN/A

Forward P/S (NTM)

ABVCN/A

BIOQN/A

Revenue (TTM)

ABVC$0

BIOQ$42M

Revenue Growth (YoY)

ABVC-100.0%

BIOQ-19.4%

Forward Rev Growth

ABVC0.0%

BIOQ0.0%

Gross Margin (TTM)

ABVC0.3%

BIOQ7.9%

Operating Margin (TTM)

ABVC0.0%

BIOQ0.0%

EBITDA Margin (TTM)

ABVC0.0%

BIOQ-0.1%

Net Margin (TTM)

ABVC0.0%

BIOQ-2.9%

FCF Margin (TTM)

ABVCN/A

BIOQ14.0%

Net Income (TTM)

ABVC$-8M

BIOQ$-1M

FCF (TTM)

ABVC$-3M

BIOQ$6M

EPS (TTM)

ABVC-$0.30

BIOQ-$1.38

ROE (TTM)

ABVC-7147.0%

BIOQ-346.0%

ROA (TTM)

ABVC-3883.0%

BIOQ-193.0%

ROIC (TTM)

ABVC-6509.0%

BIOQ-346.0%

Cash

ABVC$32K

BIOQ$11M

Debt

ABVC$859K

BIOQ$0

Net Cash/Debt

ABVC$-827K

BIOQ$11M

Current Ratio (TTM)

ABVC0.07x

BIOQ4.01x

Quick Ratio (TTM)

ABVC0.05x

BIOQ3.91x

Debt/Equity (TTM)

ABVC0.08x

BIOQ0.00x

Debt/Assets (TTM)

ABVC0.0%

BIOQ0.0%

Interest Coverage (TTM)

ABVCN/A

BIOQN/A

Net Debt/EBITDA (TTM)

ABVC0.00x

BIOQ0.00x

Beta

ABVC0.50

BIOQ-0.48

52W Performance

ABVC-69.1%

BIOQ-40.0%

YTD Performance

ABVC-54.3%

BIOQ-14.3%

% from 52W High

ABVC-70.0%

BIOQ-69.6%

% from 52W Low

ABVC40.8%

BIOQ1.5%

Asset Turnover (TTM)

ABVC0.06x

BIOQ0.66x

FCF Yield (TTM)

ABVC-10.4%

BIOQ20.2%

Earnings Yield (TTM)

ABVC-30.4%

BIOQ-4.2%

Dividend Yield (TTM)

ABVCN/A

BIOQN/A

Rule of 40

ABVC-100.0

BIOQ-5.4

EV/GP/RG

ABVCN/A

BIOQN/A

Ticker research

View ABVC research View BIOQ research

Metric	ABVC ABVC Biopharma Inc	BIOQ Bioqual Inc
Market & Valuation
Market Cap	$26M	$29M
Enterprise Value	$27M	$18M
Price	$1.00	$33.00
P/E Ratio	N/A	N/A
P/S Ratio	39.44x	0.69x
EV/Sales	40.47x	0.43x
EV/EBITDA	0.00x	7.55x
P/B Ratio	3.06x	0.84x
P/FCF Ratio	N/A	4.95x
EV/FCF	-9.95x	3.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$42M
Revenue Growth (YoY)	-100.0%	-19.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.3%	7.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-0.1%
Net Margin (TTM)	0.0%	-2.9%
FCF Margin (TTM)	N/A	14.0%
Net Income (TTM)	$-8M	$-1M
FCF (TTM)	$-3M	$6M
EPS (TTM)	-$0.30	-$1.38
ROE (TTM)	-7147.0%	-346.0%
ROA (TTM)	-3883.0%	-193.0%
ROIC (TTM)	-6509.0%	-346.0%
Financial Health
Cash	$32K	$11M
Debt	$859K	$0
Net Cash/Debt	$-827K	$11M
Current Ratio (TTM)	0.07x	4.01x
Quick Ratio (TTM)	0.05x	3.91x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	-0.48
52W Performance	-69.1%	-40.0%
YTD Performance	-54.3%	-14.3%
% from 52W High	-70.0%	-69.6%
% from 52W Low	40.8%	1.5%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.66x
FCF Yield (TTM)	-10.4%	20.2%
Earnings Yield (TTM)	-30.4%	-4.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-5.4
EV/GP/RG	N/A	N/A
Ticker research	View ABVC research	View BIOQ research